Prosecution Insights
Last updated: October 02, 2026
Application No. 17/708,761

AXIAL AND ROTATIONAL LOCKING OF DUAL CATHETER SYSTEMS

Non-Final OA §102§103
Filed
Mar 30, 2022
Priority
Apr 09, 2021 — provisional 63/172,888
Examiner
DESANTO, MATTHEW F
Art Unit
3700
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
2 (Non-Final)
60%
Grant Probability
Moderate
2-3
OA Rounds
0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
408 granted / 675 resolved
-9.6% vs TC avg
Strong +37% interview lift
Without
With
+36.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
5 currently pending
Career history
680
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
38.5%
-1.5% vs TC avg
§102
29.6%
-10.4% vs TC avg
§112
16.2%
-23.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 675 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election of Group I (claims 1-8) in the reply filed on 01/27/2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Claims 9-20 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected group, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 01/27/2025. Information Disclosure Statement The information disclosure statement (IDS) submitted on 03/30/2022 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-3, 6, and 8 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Benjamin et al. (U.S. Patent Application Publication No. 20100004730 A1). Regarding claim 1, Benjamin et al. discloses an apparatus (Fig. 4, catheter system 100) comprising: an outer catheter (Fig. 4, introducer catheter 102) comprising an outer catheter shaft (Fig. 4, introducer sheath 110) and an outer catheter hub (Fig. 5, introducer main body 106), wherein the outer catheter defines an outer catheter passageway extending along a catheter axis (see Fig. 12, structures such as the distal tip 162 can be advanced through introducer catheter 102), wherein the outer catheter hub is located at a proximal end of the outer catheter shaft (see Fig. 4, distal end of introducer sheath 110 is defined at distal tip 162); an inner catheter (Fig. 4, delivery catheter 104) comprising an inner catheter shaft (Fig. 7, outer sheath 122) and an inner catheter hub (Fig. 4, main body 140) located at a proximal end of the inner catheter shaft (see Fig. 7, distal end of outer sheath 122 is defined at distal tip 162), the inner catheter shaft is adapted to be inserted into the outer catheter (see Fig. 12); and an intermediate hub located between the inner and outer catheters (Fig. 5, hub portion 108), wherein the intermediate hub comprises a deformable component positioned around at least a portion of the inner catheter shaft (see Fig. 12, para. 0068, annular seal member 120), wherein the deformable component is adapted to be inserted into the outer catheter hub such that the inner catheter is restricted, rotationally about and axially along the catheter axis, relative to the outer catheter (para. 0068, para. 0077-0078). Regarding claim 2, Benjamin et al. discloses apparatus of claim 1, wherein the outer catheter passageway at the outer catheter hub defines a constant diameter (see Fig. 6B, para. 0059, the proximal end of main body 106 must have a constant diameter in order for its threads to engage with hub portion 108). Regarding claim 3, Benjamin et al. discloses the apparatus of claim 1, wherein the deformable component extends from an outer surface of the inner catheter shaft by a thickness of less than or equal to 10 mm (see Fig. 12, annular seal member 120 extends a non-zero distance from the outer surface of delivery catheter 104). Regarding claim 6, Benjamin et al. discloses the apparatus of claim 1, wherein the deformable component completely surrounds the inner catheter shaft (para. 0068). Regarding claim 8, Benjamin et al. discloses the apparatus of claim 1, wherein the deformable component comprises an elastomeric material (para. 0068). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 4 is rejected under 35 U.S.C. 103 as being unpatentable over Benjamin et al. (U.S. Patent Application Publication No. 20100004730 A1) in view of Drake et al. (U.S. Patent Application Publication No. 20130123753 A1). Regarding claim 4, Benjamin et al. discloses the apparatus of claim 1. Benjamin et al. fails to teach wherein the deformable component extends along a length of the inner catheter shaft for a distance of about 15-20 mm. However, Drake et al. teaches an apparatus (Fig. 2a, catheter 100), comprising an inner catheter shaft (see Fig. 2b, a sub-selecting catheter can be exchanged for large diameter guide wire 200') and a deformable component (Fig. 3a, sealing assembly 30). The deformable component extends along a length of the inner catheter shaft for a distance of about 15-20 mm (see para. 0032, para. 0042, Figs. 5a-5d, the maximum unexpanded diameter of funnel-like segment 503 dofm is 0.05 in, the seal zone 101s diameter can expand from approximately 1% to 1000% (the circumference of funnel-like segment 503 can range from 3.99 mm to 43.88 mm)). It would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to modify the deformable component of Benjamin et al. to extend along a length of the inner catheter shaft for a distance of about 3.99 mm to 43.88 mm, as taught by Drake et al., in order to accommodate passage therethrough of a variety of catheters that range in outer diameter (para. 0032). Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Benjamin et al. (U.S. Patent Application Publication No. 20100004730 A1) in view of Schertiger et al. (U.S. Patent Application Publication No. 20100211049 A1). Regarding claim 5, Benjamin et al. discloses the apparatus of claim 1, wherein the deformable component extends between a proximal region (see Fig. 12, proximal end of annular seal member 120) and a distal region (see Fig. 12, distal end of annular seal member 120). Benjamin et al. fails to teach wherein the deformable component tapers inwardly from the proximal region to the distal region. However, Schertiger et al. teaches an apparatus (Fig. 1, telescoping intermittent catheter 1), comprising an inner shaft (Fig. 1, proximal section 2) and a deformable component (Fig. 5, coupling ring 16). The deformable component tapers inwardly from a proximal region to a distal region (see Fig. 5). It would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to modify the deformable component of Benjamin et al. to taper inwardly from the proximal region to the distal region, as taught by Schertiger et al., in order to lock the catheter in its position (para. 0065). Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Benjamin et al. (U.S. Patent Application Publication No. 20100004730 A1) in view of Goral et al. (U.S. Patent Application Publication No. 20180361119 A1). Regarding claim 7, Benjamin et al. discloses the apparatus of claim 1. Benjamin et al. fails to teach wherein the deformable component is inserted into the outer catheter hub by a distance of about 5-10 mm. However, Goral et al. teaches an apparatus (Fig. 1, catheter assembly 10), wherein the deformable component (Fig. 1, membrane 72 of seal member 18) is inserted into the outer catheter hub (Fig. 1, catheter hub 12) by a distance of about 5-10 mm (see Fig. 1, Fig. 6, para. 0055, para. 0058, para. 0062, the proximal end of membrane 72 is spaced from the opening 21 at the proximal end 20 of the catheter hub 12 by about 0.28 inches (the sum of lp and dp, about 7.112 mm)). It would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to modify the apparatus component of Benjamin et al. to contain the deformable component inserted into the outer catheter hub by a distance of about 7.122 mm, as taught by Goral et al., in order to seal a cavity of the outer catheter hub (para. 0058). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMBER ROSE VENTURA whose telephone number is (703)756-5929. The examiner can normally be reached Monday - Thursday 8 am - 5 pm, Friday 8 am - 4 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, KEVIN SIRMONS can be reached on (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AMBER R VENTURA/Examiner, Art Unit 3783 /KAMI A BOSWORTH/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Mar 30, 2022
Application Filed
Apr 07, 2025
Non-Final Rejection mailed — §102, §103
Jun 26, 2025
Response Filed
Sep 28, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746368
Rapidly Insertable Central Catheters, Catheter Insertion Assemblies, and Methods
4y 4m to grant Granted Sep 29, 2026
Patent 12728196
AUTOMATIC INJECTION DEVICE HAVING A MAGNETIC DRIVE SYSTEM
5y 5m to grant Granted Sep 08, 2026
Patent 10881796
Automatic Medication Injection Device
4y 6m to grant Granted Jan 05, 2021
Patent 10874831
Devices and Methods for Accessing the Vasculature of a Patient
5y 2m to grant Granted Dec 29, 2020
Patent 10828418
SLIDE-ACTIVATED ANGLED INSERTER AND CANTILEVERED BALLISTIC INSERTION FOR INTRADERMAL DRUG INFUSION
2y 8m to grant Granted Nov 10, 2020
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
60%
Grant Probability
97%
With Interview (+36.9%)
3y 10m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 675 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month